Journal of Cancer Research and Therapeutics Close
 

Figure 4: Plots showing the means of total length, branches, junctions, and mean branch length for each combination of groups of sorafenib (0 and 2 μg/embryo) and zinc (0 and 2.5 μ/embryo). Parallel lines indicate no interaction effect. Converging lines indicate a positive interaction effect. Diverging lines indicate a negative interaction effect. S 0, sorafenib 0 μg/embryo; S 2, sorafenib 2 μg/embryo; Z 0, zinc 0 μg/embryo; and Z 2.5, zinc 2.5 μg/embryo

Figure 4: Plots showing the means of total length, branches, junctions, and mean branch length for each combination of groups of sorafenib (0 and 2 μg/embryo) and zinc (0 and 2.5 μ/embryo). Parallel lines indicate no interaction effect. Converging lines indicate a positive interaction effect. Diverging lines indicate a negative interaction effect. S 0, sorafenib 0 μg/embryo; S 2, sorafenib 2 μg/embryo; Z 0, zinc 0 μg/embryo; and Z 2.5, zinc 2.5 μg/embryo